Key Findings
The smallest cellular nanodiscs consistently outperform larger versions in therapeutic performance. Experimental results show that smaller particles attach to antibodies more efficiently, interact with biological targets more rapidly, and neutralize bacterial alpha-toxin more effectively. In vivo testing on mice exposed to toxins confirmed that the smallest nanodiscs provided the highest level of protection.
Technical Details
To isolate the impact of size on biological function, the research team engineered three versions of red blood cell-derived cellular nanodiscs with diameters of approximately 71, 26, and 15 nanometers. The particles were nearly identical in all other aspects.
To explain these results, researchers utilized high-performance computing via the San Diego Supercomputer Center (SDSC) Expanse system and National Science Foundation (NSF) ACCESS allocations. Computer simulations revealed two primary drivers for the increased performance of smaller nanodiscs:
- Faster diffusion through their environment.
- A greater number of particles present for the same amount of material.
These factors combined increase the probability that the nanodiscs will encounter and bind to their intended biological targets.
Background & Context
Cellular nanodiscs are tiny particles made from natural cell membranes designed to mimic living cell functions. While their potential for vaccines, detoxification, and drug delivery was previously known, the specific influence of particle size remained an unanswered question. This interdisciplinary study involved the Halıcıoğlu School of Data Science and Computing and the Aiiso Yufeng Li Family Department of Chemical and Nano Engineering at UC San Diego, led by professors Liangfang Zhang and Kesong Yang.
Significance & Outlook
The study establishes new design principles for membrane-based therapeutics, moving away from trial-and-error experimentation toward a model that integrates simulation with laboratory validation. By identifying size as a fundamental driver of performance, this research provides a blueprint for optimizing next-generation nanomedicines for drug delivery and toxin neutralization.
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
